Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 2,940 shares of the company’s stock in a transaction that occurred on Tuesday, September 25th. The shares were purchased at an average price of $7.98 per share, with a total value of $23,461.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, September 19th, Levin Capital Strategies, L.P. purchased 40 shares of Fluidigm stock. The shares were purchased at an average price of $8.22 per share, with a total value of $328.80.
  • On Tuesday, September 11th, Levin Capital Strategies, L.P. purchased 17 shares of Fluidigm stock. The shares were purchased at an average price of $8.42 per share, with a total value of $143.14.
  • On Thursday, September 6th, Levin Capital Strategies, L.P. purchased 201 shares of Fluidigm stock. The shares were purchased at an average price of $7.85 per share, with a total value of $1,577.85.
  • On Thursday, August 30th, Levin Capital Strategies, L.P. purchased 18 shares of Fluidigm stock. The shares were purchased at an average price of $7.86 per share, with a total value of $141.48.
  • On Wednesday, August 15th, Levin Capital Strategies, L.P. purchased 25,500 shares of Fluidigm stock. The shares were purchased at an average price of $6.78 per share, with a total value of $172,890.00.
  • On Wednesday, August 8th, Levin Capital Strategies, L.P. purchased 21 shares of Fluidigm stock. The shares were purchased at an average price of $6.76 per share, with a total value of $141.96.
  • On Thursday, August 2nd, Levin Capital Strategies, L.P. purchased 29 shares of Fluidigm stock. The shares were purchased at an average price of $6.36 per share, with a total value of $184.44.
  • On Tuesday, July 31st, Levin Capital Strategies, L.P. purchased 2,692 shares of Fluidigm stock. The shares were purchased at an average price of $6.40 per share, with a total value of $17,228.80.
  • On Friday, July 27th, Levin Capital Strategies, L.P. purchased 20,029 shares of Fluidigm stock. The shares were purchased at an average price of $6.14 per share, with a total value of $122,978.06.
  • On Thursday, July 12th, Levin Capital Strategies, L.P. purchased 54 shares of Fluidigm stock. The shares were purchased at an average price of $6.27 per share, with a total value of $338.58.

NASDAQ FLDM traded down $0.16 on Thursday, reaching $7.53. 232,400 shares of the company were exchanged, compared to its average volume of 186,476. The firm has a market capitalization of $307.83 million, a P/E ratio of -6.23 and a beta of 3.44. The company has a debt-to-equity ratio of 4.79, a quick ratio of 1.64 and a current ratio of 2.05. Fluidigm Co. has a fifty-two week low of $4.43 and a fifty-two week high of $8.62.

Fluidigm (NASDAQ:FLDM) last released its quarterly earnings data on Thursday, August 2nd. The medical research company reported ($0.42) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.03). The company had revenue of $26.43 million for the quarter, compared to analyst estimates of $26.30 million. Fluidigm had a negative return on equity of 104.75% and a negative net margin of 53.65%. sell-side analysts forecast that Fluidigm Co. will post -0.99 EPS for the current year.

FLDM has been the subject of several research reports. BidaskClub upgraded Fluidigm from a “hold” rating to a “buy” rating in a research report on Wednesday, September 12th. Zacks Investment Research upgraded Fluidigm from a “sell” rating to a “hold” rating in a research report on Thursday, September 20th. Finally, ValuEngine raised Fluidigm from a “sell” rating to a “hold” rating in a research note on Saturday, June 2nd.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. LMR Partners LLP acquired a new position in Fluidigm during the second quarter worth $144,000. Wells Fargo & Company MN boosted its stake in Fluidigm by 64.8% during the first quarter. Wells Fargo & Company MN now owns 28,945 shares of the medical research company’s stock worth $169,000 after buying an additional 11,377 shares during the last quarter. New York State Common Retirement Fund boosted its stake in Fluidigm by 47.9% during the first quarter. New York State Common Retirement Fund now owns 38,900 shares of the medical research company’s stock worth $227,000 after buying an additional 12,600 shares during the last quarter. Fairpointe Capital LLC acquired a new position in Fluidigm during the second quarter worth $238,000. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new position in Fluidigm during the second quarter worth $240,000. 96.73% of the stock is currently owned by institutional investors.

About Fluidigm

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system.

Recommended Story: Why is the conference call important?

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.